Tech Transfer eNews Blog

Deerfield and Dana-Farber create commercialization partnership in $130M deal


By Jesse Schwartz
Published: February 10th, 2021

Deerfield Management is still at it, creating yet another of its commercialization entities with an academic partner – this time, with the Dana-Farber Cancer Institute.

Deerfield will invest up to $130 million over 10 years to develop Dana-Farber research discoveries into actual treatments for patients. The project, dubbed Riverway Discoveries, represents the first time Deerfield has tapped one of its academic partners a second time. Their first partnership, struck in November 2018, established the Center for Protein Degradation at Dana-Farber with an $80 million investment.

Deerfield has been arguably the most active player in academic partnering, establishing big-ticket collaborations with leading institutions including Harvard, Columbia, Johns Hopkins, and the University of Illinois at Chicago.

“Translational funding in biomedical research, when the promise of success is not obvious or guaranteed, can often be the engine that ensures innovative research moves forward, paving the way for important discoveries and new and better therapies,” said Dana-Farber President and CEO Laurie Glimcher, MD. “I am hopeful that this investment by Deerfield at Dana-Farber now will eventually help improve the lives of people with cancer everywhere.”

A Riverway committee drawn from Dana-Farber and Deerfield will start considering proposals from Dana-Farber researchers later this month, and Deerfield will fund selected projects as well as provide operational support.

Source: Fierce Biotech

Posted under: Tech Transfer e-News

Twitter Facebook Linkedin Pinterest Email

No Comments so far ↓

There are no comments yet...Kick things off by filling out the form below.

Leave a Comment